admin

Stories by admin

New Publication: FierceBiotech IT

You asked, and we listened. One area of drug development we are frequently asked to cover is the use of IT in clinical research, development and commercialization. As a result, the FierceBiotech team

Luxembourg launches new bioscience initiative

The Luxembourg government has turned to three prominent biomedical science leaders in the U.S. for an international collaboration to establish a bioscience center in the heart of the European Union.

Inspire Pharma shares soar 75% on CF data

Shares of Durham, NC-based Inspire Pharmaceuticals took off this morning after researchers announced that a late-stage trial of its cystic fibrosis therapy produced promising results. Patients taking

Tercica shares skyrocket following takeover bid

Moving fast, investors swiftly bid up the value of Tercica's stock yesterday afternoon after hearing that France's Ipsen would pay $9 a share to acquire all the stock in the company it didn't already

Gentium shares slide on safety board concerns

After hearing that an independent safety board raised concerns about late stage data on Gentium's drug Defibrotide, investors shaved off about 30 percent of its stock's value this morning. The board

SPOTLIGHT: Anesiva inks $114M licensing deal

Transcription Factor Therapeutics has licensed the worldwide rights to Anesiva's NF-kB Decoy program, which includes the clinical drug candidate Avrina. NF-kB Transcription Factor Decoy inhibits

Italy's Creabilis garners €20M in Series A

The Italian biotech Creabilis Therapeutics has raised €20 million from a pair of leading venture capital groups. The money is earmarked for three mid-stage studies of CT327 for psoriasis and